CSL · 1 day ago
Director, Search & Evaluation Early TA Lead
Greater Boston
Full-time
Hybrid
Director/Executive
12+ years expCSL is a biotech company focused on delivering impactful therapies for patients. They are seeking a Director, Search & Evaluation Early TA Lead to lead strategic sourcing and evaluation of external innovation opportunities in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas.
BiotechnologyHealth CareHealth DiagnosticsMedical
Hiring Manager
Jamie O'Malley
Responsibilities
Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy
Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations
Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets
Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions
Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities
Qualification
Required
12+ years in biopharma with significant experience in external innovation, search & evaluation, or business development
Advanced degree required (PhD, MD, or equivalent)
Deep scientific expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas
Proven track record of leading due diligence and closing early-stage deals
Strong network within biotech, academia, and pharma BD organizations
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase